Associate Professor of Medicine

Nephrology

Orlando M. Gutierrez, MD is an expert in the field of Nephrology. He studied medicine at University of Toledo College of Medicine. He received awards:"Regional Top Doctor". Orlando Gutierrez is a published physician. He published 30 publications, including: 'The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.' He accepts Medicare.

Publications

---

• Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
• The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.
• Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.
• Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
• Obesity, metabolic health, and the risk of end-stage renal Disease.
• Validation Study of Medicare Claims to Identify Older US Adults With CKD Using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
• Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females.
• N-Terminal Pro-B-type Natriuretic Peptide and Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort.
• Dietary Patterns and Risk of Death and Progression to ESRD in Individuals With CKD: A Cohort Study.
• Contribution of food additives to sodium and Phosphorus content of diets rich in processed foods.
• Incident ESRD and Treatment-Resistant Hypertension: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
• Metabolic Subtypes and Risk of Mortality in Normal Weight, Overweight, and Obese Individuals With CKD.
• Chronic Kidney disease in African Americans: past, present, and future: introduction.
• Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic Kidney disease.
• Association between urinary albumin excretion and coronary heart Disease in black vs white adults.
• Prevalence of Apparent Treatment-Resistant Hypertension among Individuals With CKD.
• Cardiovascular risk factors in CKD associate With both ESRD and mortality.
• Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
• α-Klotho and Kidney Function Decline: An Important Step Forward in Understanding the Link Between Mineral Metabolism and Kidney Disease Progression.
• Fibroblast growth factor 23, klotho, and disordered mineral metabolism in chronic Kidney disease: unraveling the intricate tapestry of events and implications for ther...
• Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
• Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic Kidney disease.
• Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic Kidney disease.
• Healthy Behaviors, Risk Factor Control and Awareness of Chronic Kidney Disease.
• Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
• Plasma gelsolin and circulating actin correlate With hemodialysis mortality.
• The Connection between Dietary Phosphorus, Cardiovascular Disease, and Mortality: Where We Stand and What We Need to Know.
• Associations of Fibroblast Growth Factor-23 With Markers of Inflammation, Insulin Resistance and Obesity in Adults.
• Low income, community poverty and risk of end stage renal Disease.

Schools

---

• University of Toledo College of Medicine

Procedures Preformed

---

• Hemodialysis
• Peritoneal Dialysis

Conditions Treated

---

• Acidosis
• Acute Kidney Failure
• Amyloidosis
• Calcium Metabolism Disorders
• View All

Doctors Specialties

---

• Nephrology

Accepted Insurances

---

Awards

---

• Regional Top Doctor

Education

---

• Brigham and Women's Hospital
• Massachusetts General Hospital
• University of Toledo College of Medicine

Hospital

---

• University of Alabama Hospital
• Birmingham Veterans Affairs Medical Center

Drug Facts

---

NPI NUMBER		1932141538
NPPES Provider LastName		GUTIERREZ
NPPES Provider FirstName		ORLANDO
NPPES Provider ZIPCode		352332110
NPPES Provider State		AL
Specialty Description		Nephrology
Total Claim Count		154.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1932141538
Last Name Of The Provider	GUTIERREZ
First Name Of The Provider	ORLANDO
View All

Similar Doctors

---

	Dr. Michael Allon, MD This Doctor is OpenDoctor Recommended.
	Dr. John J. Curtis, MD
	Dr. Anupam Agarwal, MD
	Dr. Clifton E. Kew II, MD This Doctor is OpenDoctor Recommended.
	Dr. James R. Reed, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer L. Hughes, MD
	Donald L. Quinn, PA This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog